Becky Ancira Robertson
LightNews LightNews
banner
ancirabecky.bsky.social
Becky Ancira Robertson
@ancirabecky.bsky.social
1.7K followers 3.4K following 2.6K posts
Survivor. Proud mother. Teacher. Activist. Trying to make a difference.
#PatientAdvocate #longcovidawareness #LCDC #March15 #ValueCognition #WHN

Interview with @theWHN :
https://youtu.be/YUgcqJ-m7C0
Posts Replies Media Videos
Reposted by Becky Ancira Robertson
thailandmedical.bsky.social
Celiac Plexus Block Brings Major Relief for Long COVID Gut Issues

www.thailandmedical.news/news/celiac-...
Celiac Plexus Block Brings Major Relief for Long COVID Gut Issues - Thailand Medical News
www.thailandmedical.news
November 25, 2025 at 6:25 AM
ancirabecky.bsky.social
open.substack.com/pub/insideme...
Scoop: The apparent new #2 at CDC is a top ivermectin prescriber who ended Louisiana’s vaccine-promotion media campaigns.
The current Surgeon General of Louisiana has made headlines recently, including for allegedly burying a whooping cough outbreak.
open.substack.com
November 25, 2025 at 7:42 AM
ancirabecky.bsky.social
ifpnews.com/rapid-spread...
Rapid Spread Of H3N2 Influenza Across Iran - Iran Front Page
The head of the Center for Communicable Disease Control at the Iranian Health Ministry has warned of a high-speed spread of Influenza A, H3N2 subtype, noting that the virus has undergone some changes ...
ifpnews.com
November 24, 2025 at 10:52 PM
Reposted by Becky Ancira Robertson
microbesinfo.bsky.social
Long #COVID’s shadow lingers ...

| #LongCOVID | #coronavirus | #COVID19 | #SARSCoV2 | #pathogen | #infections | Via @forbes.com
Long COVID’s Shadow Lingers
Long COVID has exposed both the limits of current clinical science and the challenges of pharmaceutical strategy
www.forbes.com
November 24, 2025 at 10:01 PM
ancirabecky.bsky.social
www.cidrap.umn.edu/respiratory-...
3 studies: Nirsevimab highly effective against severe RSV in infants; intervention boosts uptake
www.cidrap.umn.edu
November 24, 2025 at 10:21 PM
ancirabecky.bsky.social
www.deccanchronicle.com/southern-sta...
AU Researchers Discover New Coronavirus That Evades Vaccines
Researchers discover spike protein can shift states and hide from antibodies.
www.deccanchronicle.com
November 24, 2025 at 5:56 AM
ancirabecky.bsky.social
open.substack.com/pub/peoplesc...
One Day Left to Tell CDC: Protect Childhood Vaccinations!
Public Comments to the CDC’s ACIP vaccine committee closes Monday, Nov 24 at 11:59 pm EST. Children must be protected from infectious diseases through access to vaccines.
open.substack.com
November 24, 2025 at 5:22 AM
ancirabecky.bsky.social
open.substack.com/pub/insideme...
NIH Pandemic Preparedness Takedown. With Dr. Angela Rasmussen and Dr. Jeremy Faust
A recording from Jeremy Faust, MD's live video
open.substack.com
November 24, 2025 at 5:07 AM
Reposted by Becky Ancira Robertson
andreastudiescovid.bsky.social
It shouldn't take this long to get diagnosed. For anyone. If doctors would read the literature they'd know that it is not necessary to rule out every other malady known to man to Dx long COVID, especially when all of the patient's symptoms fit with long COVID, and they have no symptoms that do not.
November 24, 2025 at 4:04 AM
ancirabecky.bsky.social
open.substack.com/pub/teamshum...
FYI: December CDC vaccine meeting, 22 November 2025
CDC ACIP’s December meeting: demand vaccines.
open.substack.com
November 24, 2025 at 4:17 AM
Reposted by Becky Ancira Robertson
elisaperego78.bsky.social
Costs of #LongCovid "are estimated at an average annual burden of $1 trillion globally"

www.nature.com/articles/s41...
www.nature.com
November 23, 2025 at 10:57 PM
Reposted by Becky Ancira Robertson
playon.bsky.social
"No pharmacological or behavioral therapy has yet shown clear benefit for cognitive Long COVID."

www.forbes.com/sites/gregli...
Long COVID’s Shadow Lingers
Long COVID has exposed both the limits of current clinical science and the challenges of pharmaceutical strategy
www.forbes.com
November 24, 2025 at 3:17 AM
Reposted by Becky Ancira Robertson
spiritsofland.bsky.social
Covid kills 10 times more people than seasonal flu (influenza)

bsky.app/profile/mori...
moriartylab.bsky.social Tara Moriarty @moriartylab.bsky.social · Nov 4
INFLUENZA VS COVID-19 DEATHS IN CANADA
This thread is also available on the C-19 website, starting on page 8, for easier reading.
Risk Scenario Estimator Based on Canadian Forecast
https://t.co/sl9i5g5QKa
#CovidIsAirborne #CovidIsntOver #MaskUp #YallMasking #CleanTheAir
November 22, 2025 at 12:25 AM
Reposted by Becky Ancira Robertson
spiritsofland.bsky.social
Covid is airborne

Covid is airborne
healthydebate.ca/2025/03/topi...
How denial of airborne COVID transmission broke the world - Healthy Debate
Five years later, the greatest basic science failure in generations caused the pandemic harms highlighted by people across the political spectrum, and broke our social cohesion.
healthydebate.ca
November 22, 2025 at 12:25 AM
ancirabecky.bsky.social
www.sciencealert.com/ancient-kill...
Ancient Killer Is Rapidly Becoming Resistant to Antibiotics, Scientists Warn
Despite having plagued humans for millennia, typhoid fever is rarely considered a threat in developed countries today.
www.sciencealert.com
November 22, 2025 at 1:02 AM
Reposted by Becky Ancira Robertson
mecfssd.bsky.social
Join the LC-REVITALIZE Long COVID Study!

Adults 18–65 with persistent Long COVID can participate in San Diego ([email protected]
| 619-324-8677) or 7 other global sites. 6 months, 8 visits, FDA-approved drugs tested. Reimbursement provided.

clinicaltrials.gov/study/NCT069...
Long COVID Clinical Research Treatment Study at Family Health Centers of San Diego. Researchers are recruiting adults diagnosed with or experiencing signs of Long COVID to participate in the LC-Revitalize study. The study tests FDA-approved drugs upadacitinib and pirfenidone to determine their safety and effectiveness. Participation lasts six months and includes eight visits with physical assessments, blood draws, questionnaires, and evaluation of cardiovascular and pulmonary health. Participants will be reimbursed for completed visits. Eligible participants must be 18 to 65 years old, able to provide consent in English or Spanish, and have had COVID-19 within the past four years, confirmed by PCR, antigen test, or probable infection with epidemiologic link. Participants must have persistent or new Long COVID symptoms for at least three months, lasting two months or more with no other explanation. Participants must experience at least one symptom cluster: fatigue, breathing difficulties, circulation problems, memory, thinking, or communication issues, or muscle and joint pain. Interested individuals should contact the FHCSD study team via email at longcovid@fhcsd.org or phone/text at 619-324-8677. IRB number IRB-25-0209, approval date October 7, 2025.
November 21, 2025 at 8:50 PM
ancirabecky.bsky.social
www.scientificamerican.com/article/cdc-...
The CDC Is Ending Its Monkey Research Program. Here’s Why That Matters
The Centers for Disease Control and Prevention’s decision to end its monkey research program will affect studies involving some 200 macaques, and the fate of the animals is unclear
www.scientificamerican.com
November 22, 2025 at 12:16 AM
ancirabecky.bsky.social
open.substack.com/pub/pandemic...
The Greatest Mistake of Debunking Anti-Vaccine Myths
The F.A.S. Theory of Social Media Grifting
open.substack.com
November 22, 2025 at 12:12 AM
ancirabecky.bsky.social
www.cidrap.umn.edu/chronic-wast...
While no one was watching: Tenuous status of CDC prion unit, risk of CWD to people worry scientists
www.cidrap.umn.edu
November 22, 2025 at 12:11 AM
Reposted by Becky Ancira Robertson
scripps.edu
Founder and director of the Scripps Research Translational Institute, @erictopol.bsky.social, and Julia Moore Vogel, co–principal investigator of the Long COVID Treatment Trial, were featured in @wired.com, sharing insights on a nationwide study testing GLP-1s for long COVID.
Weight-Loss Drug Zepbound Is Being Tested as a Treatment for Long Covid
GLP-1s are being studied for a wide range of conditions. Now, scientists will test whether their anti-inflammatory properties can help alleviate symptoms of long Covid.
ow.ly
November 21, 2025 at 9:32 PM
ancirabecky.bsky.social
open.substack.com/pub/johndupu...
Neurological impact of Covid on children, Canada craps the measles bed, PPE prevents healthcare infections, and more
Bonus Thank you Alice Wong and Leslie Lee III
open.substack.com
November 21, 2025 at 11:25 PM
ancirabecky.bsky.social
open.substack.com/pub/insideme...
Preview: Is Bird Flu Back? With guest Dr. Angela Rasmussen. (Yes, we managed to book her again 🙌)
Join us today, Friday, November 21 at 11 a.m. ET on Instagram Live.
open.substack.com
November 21, 2025 at 10:57 PM
ancirabecky.bsky.social
open.substack.com/pub/longcovi...
GLP-1 Drugs For Long COVID: Inside the New Scripps LoCITT Trial
A conversation with principal investigator Dr. Julia Moore-Vogel
open.substack.com
November 21, 2025 at 3:41 AM
ancirabecky.bsky.social
www.cidrap.umn.edu/tuberculosis...
Phase 2 data suggest new drug could unlock shorter TB treatment
www.cidrap.umn.edu
November 21, 2025 at 3:27 AM
ancirabecky.bsky.social
www.scientificamerican.com/article/halt...
Halted NIH Clinical Trials List Reveals Slashed Treatments for Cancer, COVID and Minority Health
The National Institutes of Health has canceled funding for at least 383 clinical trials in the last year, affecting some 74,000 participants
www.scientificamerican.com
November 21, 2025 at 12:51 AM